Increasing enrollment in drug trials: The need for greater transparency about the social value of research in recruitment efforts

Mayo Clinic Proceedings

Volumn 88, Issue 5, 2013, Pages 442-445

  Yarborough, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; DRUG RESEARCH; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; INFORMED CONSENT; MEDICAL CARE; NOTE; PATIENT PARTICIPATION; RESEARCH SUBJECT; SOCIAL ASPECT; SOCIAL VALUE; UNITED STATES; VOLUNTEER; WORKSHOP; ARTICLE; MEDICAL RESEARCH; METHODOLOGY; PATIENT SELECTION; SOCIAL PSYCHOLOGY;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT SELECTION; SOCIAL VALUES; UNITED STATES;

MLCS; MLOWN;

EID: 84880156289     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.03.001     Document Type: Short Survey

References (14)

1. Probstfield JL, Frye RL. Strategies for recruitment and retention of participants in clinical trials. JAMA. 2011; 306(16):1798-1799.
2. Harris J. Scientific research is a moral duty. J Med Ethics. 2005; 31(4):242-248. (Pubitemid 40542138)
3. Rhodes R. Rethinking research ethics. Am J Bioeth. 2005;5(1): 7-28. (Pubitemid 41674014)
4. Schaefer GO, Emanuel EJ, Wertheimer A. The obligation to participate in biomedical research. JAMA. 2009;302(1):67-72.
5. Gagne JJ, Choudhry NK. How many "me-too" drugs is too many? JAMA. 2011;305(7):711-712.
6. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701-2711. (Pubitemid 30337334)
7. Relman AS, Angell M. America's other drug problem: how the drug industry distorts medicine and politics. New Repub. 2002; 227(25):27-41.
8. Kesselheim AS, Robertson CT, Myers JA, et al. A randomized study of how physicians interpret research funding disclosures. N Engl J Med. 2012;367(12):1119-1127.
9. Sharp RR, Yarborough M. Informed trust and the financing of biomedical research. J Law Med Ethics. 2006;34(2): 460-464.
10. Cook AF, Hoas H. Trading places: what the research participant can tell the investigator about informed consent. J Clin Res Bioeth. 2011;2:121.
11. Hill KP, Ross JS, Egilman DS, Krumholz HM. The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med. 2008;149(4):251-258.
12. Schneider CE. Reaching disclosure. Hastings Cent Rep. 2005; 35(1):12-13. (Pubitemid 40712157)
13. Yarborough M, Fryer-Edwards K, Geller G, Sharp RR. Transforming the culture of biomedical research from compliance to trustworthiness: insights from nonmedical sectors. Acad Med. 2009;84(4):472-477.
14. Casadevall A, Fang FC. Reforming science: methodological and cultural reforms. Infect Immun. 2012;80(3):891-896.